Blood clot-dissolving drug may treat critical Covid-19 patients – WeForNews

New York, March 27 : In the sea of drugs currently being explored to treat COVID-19, researches at University of Colorado and MIT have proposed a drug that is derived from a protein called tissue plasminogen activator (tPA) and is commonly used to treat stroke and heart attack.

powered by Advanced iFrame free. Get the Pro version on CodeCanyon.

Leave a Reply

Your email address will not be published. Required fields are marked *